In stock
SKYRIZI 600 MG PER 10 ML VIAL
In stock
Only 1 left
SKU
10331010730
SKYRIZI 600 mg/10 mL Vial is an AbbVie biologic therapy containing risankizumab, specifically approved for the induction treatment of moderately to severely active Crohn's disease and ulcerative colitis. It targets the IL-23 pathway to reduce inflammation and alleviate symptoms. This prescription-only medication is administered as an intravenous infusion by a healthcare professional.
Product Description
Skyrizi 600 mg/10 mL Vial contains risankizumab, a targeted biologic therapy developed by AbbVie. This medication is specifically designed to treat certain chronic inflammatory conditions by selectively blocking the IL-23 pathway, a key driver of inflammation.This highly effective biological medication targets specific inflammatory pathways to provide significant relief for chronic conditions, primarily for induction therapy in adults with moderately to severely active Crohn's disease and ulcerative colitis.
Benefits of Use
- Highly effective in achieving clinical remission and endoscopic improvement in patients with moderately to severely active Crohn's disease and ulcerative colitis.
- Targets the IL-23 pathway, a key driver of inflammation in these conditions, leading to reduced inflammation.
- Helps alleviate debilitating symptoms such as abdominal pain, frequent diarrhea, and rectal bleeding.
- Contributes to an improved quality of life for patients managing these chronic inflammatory conditions.
How to Use
- Skyrizi 600 mg/10 mL Vial is for intravenous (IV) infusion only and must be prepared and administered by a qualified healthcare professional.
- The typical induction dose for moderately to severely active Crohn's disease and ulcerative colitis is 600 mg, administered as an intravenous infusion over at least one hour.
- Induction doses are usually given at Weeks 0, 4, and 8.
- Following the induction phase, maintenance therapy typically transitions to subcutaneous administration (e.g., 360 mg). Always adhere to your doctor's prescribed dosing schedule and administration instructions.
Cautions & Warnings
- Increased Risk of Infection: May increase the risk of serious infections. Patients should be evaluated for tuberculosis (TB) infection prior to initiating treatment and monitored closely for signs and symptoms of infection during and after treatment.
- Hypersensitivity Reactions: Serious allergic reactions, including anaphylaxis, may occur. Seek immediate medical attention if you experience symptoms such as rash, hives, swelling of the face, lips, mouth, or tongue, or difficulty breathing.
- Liver Enzyme Elevations: Elevations of liver enzymes have been reported. Regular monitoring of liver enzymes may be necessary as directed by your healthcare provider.
- Vaccinations: Patients should be up-to-date with all age-appropriate immunizations prior to starting Skyrizi. Live vaccines should not be administered during treatment.
- Pregnancy and Breastfeeding: Consult your doctor before using if you are pregnant, planning to become pregnant, or breastfeeding.
- Keep out of reach of children.
Ingredients
Active Ingredient: Risankizumab 600 mg per 10 mL vial.
Inactive Ingredients: L-histidine, L-histidine monohydrochloride monohydrate, polysorbate 80, sodium chloride, sodium succinate, succinic acid, water for injection.
Product Details
Manufacturer: AbbVie
Dosage Form: Concentrate for solution for intravenous infusion.
Package Size: Typically one single-dose vial per pack.
Storage: Store in a refrigerator (2°C to 8°C or 36°F to 46°F). Do not freeze. Keep the vial in the original carton to protect it from light. Do not shake the vial.
Legal Status: Prescription Only Medicine (POM).
| Gtin | 101011004569OO |
|---|---|
| Recommended Sale Price | 11103.25 |
| Is Wasfaty Product | No |
| Brand | Skyrizi |
| Ingredient Name | RISANKIZUMAB |
| SFDA Reg. No | 2106233833 |
| IBC | 101011004569OO |
| Drug Type | Prescription |
| Scientific Name | Risankizumab |
| Strength | 600 MG |
| Strength Unit | MG |
| Form | Concentrate for solution for infusion |
| Admin Route | Intravenous |
| Size | 10 ML |
| Size Unit | ML |
| Package Types | Vial |
| Package Size | 1 vial |
| shelfLife | 24 months |
| Storage conditions | Store in a refrigerator (2°C to 8°C). Do not freeze. Keep in original carton to protect from light. |
| Refrigerator Storage | Yes |
Products you might like
